Moderna Inc. experienced a notable rise in stock price, gaining investor confidence.
Moderna Inc. (NASDAQ:MRNA) went up yesterday by an impressive 8.55%, closing at CA$158.07. This surge comes as the broader market, including the S&P 500 and Nasdaq, showed signs of recovery.
Advertisement
Moderna Inc
MRNA.US
MRNA.US
Moderna Inc
WealthAwesomeMarket cap
$77.78B
52W high
$195.71
52W low
$22.28
1W change
+23.25%
Beta
1.11
Analyst Price Targets
Based on 27 analysts covering MRNA · as of Sep 17, 2026
Wall Street analysts forecast MRNA stock price to fall 38.6% over the next 12 months.
Consensus
Hold3.22 / 5.00
Avg. Target
C$119.56
-38.6% Upside
Current Price
C$194.82
Last close
Analyst Breakdown (27 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MRNA's historical volatility
30-Day Vol
315.9%
Annualized
90-Day Vol
217.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$232.91
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$206.77 | C$69.53 – C$614.87 |
| 60 trading days | C$219.45 | C$46.99 – C$1024.90 |
| 90 trading days | C$232.91 | C$35.27 – C$1538.03 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent price increase reflects renewed investor interest in Moderna, particularly in light of positive market trends and buy signals from analysts.
8.55%
The 8.55% increase in Moderna's stock price signals a strong recovery amidst a challenging market environment.
Bull case
The overall positive sentiment in the market, along with encouraging buy signals for Moderna, indicates that the company may continue to draw in investors. This is especially true as it navigates a complex economic landscape.
Bear case
Despite the recent gains, investors should stay cautious. Ongoing economic uncertainties and specific challenges within the sector could affect Moderna's future performance.
Market Context
Advertisement
The S&P 500 and Nasdaq regained their 50-day moving averages yesterday, suggesting a potential rebound in the market. This broader recovery likely contributed to the positive movement in Moderna's stock price, as investors reacted favorably to the overall bullish sentiment.
Analyst Insights
Recent reports have highlighted Moderna as a stock to watch, with analysts issuing buy signals. This renewed interest in the company shows that investors are optimistic about its future, despite the ongoing economic uncertainties.
Looking Ahead
While the recent surge is encouraging, investors should remain vigilant. The market's volatility and economic challenges could still pose risks to Moderna's performance in the coming months.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
